Among numerous mTORC1 effectors, the Myc family and hypoxia-inducible factors (HIFs) are often activated in various cancers and have been considered to confer metabolic advantages to cancer cells by enhancing the Warburg effect through transcriptional activation of glycolytic enzymes[18]. The gene discussed is MYC; the disease is cancer.